Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Minoxidil and platelet-rich plasma can help turn thin hair into thicker hair in male pattern baldness.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Cyproterone acetate effectively treats female hair loss by increasing healthy hair and decreasing unhealthy hair, but doesn't change hair thickness.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The Trust tonic is more effective than minoxidil for treating hair loss.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The document explains how to identify different hair problems using a microscope.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can cause hair growth in some areas and hair loss on the scalp.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.